Zetia (Ezetimibe) - cholestrol lowering drug approved by FDA
The Glenmark Pharmaceuticals, Mumbai got approval from the US Food and Drug Administration - USFDA for its product Zetia (Ezetimibe), a cholestrol lowering drug will be useful for fat loss and cholestrol management. The approval is issued for 10 mg Ezetimibe tablets.
The drug got 6 months marketing exclusivity until the patent expires. In 2008 the Zetia pill was sold for an yearly turnover of $1.5 billion. The main patent of the drug will expire on 2014.
